FISHER + PAYKEL HEALTH.FISHER + PAYKEL HEALTH.FISHER + PAYKEL HEALTH.

FISHER + PAYKEL HEALTH.

No trades
See on Supercharts
Next report date
Report period
H2 2023
EPS estimate
0.14EUR
Revenue estimate
‪517.88 M‬EUR
Market capitalization
‪8.92 B‬EUR
‪144.50 M‬EUR
‪917.12 M‬EUR
‪545.69 M‬
Beta (1Y)
1.82

About FISHER & PAYKEL HEALTHCARE CORP NPV

CEO
Lewis George Gradon
Headquarters
Auckland
Employees (FY)
‪6.56 K‬
Founded
1934
ISIN
NZFAPE0001S2
FIGI
BBG000CPR171
Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange FISHER + PAYKEL HEALTH. stocks are traded under the ticker FPLB.
FISHER + PAYKEL HEALTH. is going to release the next earnings report on May 28, 2024. Keep track of upcoming events with our Earnings Calendar.
FPLB earnings for the last quarter are 0.16 EUR per share, whereas the estimation was 0.15 EUR resulting in a 2.28% surprise. The estimated earnings for the next quarter are 0.10 EUR per share. See more details about FISHER + PAYKEL HEALTH. earnings.
FISHER + PAYKEL HEALTH. revenue for the last quarter amounts to ‪514.10 M‬ EUR despite the estimated figure of ‪506.10 M‬ EUR. In the next quarter revenue is expected to reach ‪450.95 M‬ EUR.
Yes, you can track FISHER + PAYKEL HEALTH. financials in yearly and quarterly reports right on TradingView.
FPLB net income for the last quarter is ‪60.85 M‬ EUR, while the quarter before that showed ‪89.14 M‬ EUR of net income which accounts for −31.73% change. Track more FISHER + PAYKEL HEALTH. financial stats to get the full picture.
FISHER + PAYKEL HEALTH. dividend yield was 1.79% in 2022, and payout ratio reached 110.06%. The year before the numbers were 1.91% and 71.13% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, FPLB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FISHER + PAYKEL HEALTH. stock right from TradingView charts — choose your broker and connect to your account.
FPLB reached its all-time high on Apr 29, 2021 with the price of 21.4 EUR, and its all-time low was 10.2 EUR and was reached on Oct 13, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 30, 2024, the company has ‪6.56 K‬ employees. See our rating of the largest employees — is FISHER + PAYKEL HEALTH. on this list?
We've gathered analysts' opinions on FISHER + PAYKEL HEALTH. future price: according to them, FPLB price has a max estimate of 16.13 EUR and a min estimate of 11.92 EUR. Read a more detailed FISHER + PAYKEL HEALTH. forecast: see what analysts think of FISHER + PAYKEL HEALTH. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FISHER + PAYKEL HEALTH. EBITDA is ‪270.35 M‬ EUR, and current EBITDA margin is 27.62%. See more stats in FISHER + PAYKEL HEALTH. financial statements.